| Literature DB >> 33152694 |
Louis Burt Nabors1, Jana Portnow2, Manmeet Ahluwalia3, Joachim Baehring4, Henry Brem5, Steven Brem6, Nicholas Butowski7, Jian L Campian8, Stephen W Clark9, Andrew J Fabiano10, Peter Forsyth11, Jona Hattangadi-Gluth12, Matthias Holdhoff5, Craig Horbinski13, Larry Junck14, Thomas Kaley15, Priya Kumthekar13, Jay S Loeffler16, Maciej M Mrugala17, Seema Nagpal18, Manjari Pandey19, Ian Parney17, Katherine Peters20, Vinay K Puduvalli21, Ian Robins22, Jason Rockhill23, Chad Rusthoven24, Nicole Shonka25, Dennis C Shrieve26, Lode J Swinnen5, Stephanie Weiss27, Patrick Yung Wen28, Nicole E Willmarth29, Mary Anne Bergman30, Susan D Darlow30.
Abstract
The NCCN Guidelines for Central Nervous System (CNS) Cancers focus on management of adult CNS cancers ranging from noninvasive and surgically curable pilocytic astrocytomas to metastatic brain disease. The involvement of an interdisciplinary team, including neurosurgeons, radiation therapists, oncologists, neurologists, and neuroradiologists, is a key factor in the appropriate management of CNS cancers. Integrated histopathologic and molecular characterization of brain tumors such as gliomas should be standard practice. This article describes NCCN Guidelines recommendations for WHO grade I, II, III, and IV gliomas. Treatment of brain metastases, the most common intracranial tumors in adults, is also described.Entities:
Year: 2020 PMID： 33152694 DOI： 10.6004/jnccn.2020.0052
Source DB: PubMed Journal: J Natl Compr Canc Netw ISSN： 1540-1405 Impact factor: 11.908